aztreonam has been researched along with bilirubin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lerner, SA; Levine, DP; Moore, RD | 1 |
| Argyle, C; McCracken, G; Mize, C; Uauy, R | 1 |
| Marks, MI; Parker, KM; Stutman, HR | 1 |
2 trial(s) available for aztreonam and bilirubin
| Article | Year |
|---|---|
Nephrotoxicity and ototoxicity of aztreonam versus aminoglycoside therapy in seriously ill nonneutropenic patients.
Topics: Aminoglycosides; Anti-Bacterial Agents; Auditory Threshold; Aztreonam; Bilirubin; Creatinine; Double-Blind Method; Female; Gram-Negative Bacterial Infections; Humans; Kidney; Male; Middle Aged; Regression Analysis; Risk Factors; Vestibule, Labyrinth | 1992 |
Metabolic tolerance to arginine: implications for the safe use of arginine salt-aztreonam combination in the neonatal period.
Topics: Ammonia; Ampicillin; Analysis of Variance; Arginine; Aztreonam; Bilirubin; Blood Glucose; Cohort Studies; Drug Evaluation; Drug Therapy, Combination; Gentamicins; Humans; Infant, Low Birth Weight; Infant, Newborn; Sepsis; Time Factors | 1991 |
1 other study(ies) available for aztreonam and bilirubin
| Article | Year |
|---|---|
Potential of moxalactam and other new antimicrobial agents for bilirubin-albumin displacement in neonates.
Topics: Anti-Bacterial Agents; Azlocillin; Aztreonam; Bilirubin; Binding Sites; Cefoperazone; Ciprofloxacin; Enoxacin; Humans; Imipenem; In Vitro Techniques; Infant, Newborn; Moxalactam; Naphthyridines; Quinolines; Serum Albumin; Thienamycins | 1985 |